Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1906

1.

Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.

Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J, Ankathil R.

J Cancer Res Clin Oncol. 2008 Jun;134(6):645-52.

PMID:
17952468
2.

Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.

De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, Velghe A, Van Meerbeeck J, Thierens H.

Mutat Res. 2007 Jul 28;631(2):101-10.

PMID:
17531525
3.

DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis.

Hu Z, Wei Q, Wang X, Shen H.

Lung Cancer. 2004 Oct;46(1):1-10.

PMID:
15364127
4.

DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population.

Chen S, Tang D, Xue K, Xu L, Ma G, Hsu Y, Cho SS.

Carcinogenesis. 2002 Aug;23(8):1321-5.

PMID:
12151350
5.

Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.

Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem MF, Keohavong P.

Carcinogenesis. 2003 Oct;24(10):1671-6.

PMID:
12844488
6.

XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.

Liu G, Zhou W, Yeap BY, Su L, Wain JC, Poneros JM, Nishioka NS, Lynch TJ, Christiani DC.

Carcinogenesis. 2007 Jun;28(6):1254-8.

PMID:
17264068
7.

Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.

Brewster AM, Jorgensen TJ, Ruczinski I, Huang HY, Hoffman S, Thuita L, Newschaffer C, Lunn RM, Bell D, Helzlsouer KJ.

Breast Cancer Res Treat. 2006 Jan;95(1):73-80.

PMID:
16319991
8.

Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.

Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P.

Carcinogenesis. 2004 Dec;25(12):2433-41.

PMID:
15333465
9.

Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan.

Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL.

BMC Cancer. 2005 Jan 28;5:12.

10.

Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.

López-Cima MF, González-Arriaga P, García-Castro L, Pascual T, Marrón MG, Puente XS, Tardón A.

BMC Cancer. 2007 Aug 16;7:162.

11.

Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.

Giachino DF, Ghio P, Regazzoni S, Mandrile G, Novello S, Selvaggi G, Gregori D, DeMarchi M, Scagliotti GV.

Clin Cancer Res. 2007 May 15;13(10):2876-81.

12.

[XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].

Yuan P, Miao XP, Zhang XM, Wang ZH, Tan W, Sun Y, Zhang XR, Xu BH, Lin DX.

Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):196-9. Chinese.

PMID:
16875604
13.

XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.

Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, Kosma VM, Uusitupa M, Hirvonen A.

Breast Cancer Res. 2005;7(6):R987-97.

14.

[Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].

Xing DY, Qi J, Tan W, Miao XP, Liang G, Yu CY, Lu WF, Zhou CN, Wu M, Lin DX.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Feb;20(1):35-8. Chinese.

PMID:
12579497
15.

Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk.

Ito H, Matsuo K, Hamajima N, Mitsudomi T, Sugiura T, Saito T, Yasue T, Lee KM, Kang D, Yoo KY, Sato S, Ueda R, Tajima K.

Carcinogenesis. 2004 Aug;25(8):1395-401.

PMID:
15044328
16.

Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.

Unal M, Güven M, Batar B, Ozaydin A, Sarici A, Devranoğlu K.

Exp Eye Res. 2007 Sep;85(3):328-34.

PMID:
17637462
17.

DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.

Batar B, Güven M, Bariş S, Celkan T, Yildiz I.

Leuk Res. 2009 Jun;33(6):759-63. doi: 10.1016/j.leukres.2008.11.005.

PMID:
19101034
18.

Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.

Kumar A, Pant MC, Singh HS, Khandelwal S.

Mutat Res. 2012 Jan 3;729(1-2):24-34. doi: 10.1016/j.mrfmmm.2011.09.001.

PMID:
21945240
19.

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC.

J Clin Oncol. 2004 Jul 1;22(13):2594-601.

PMID:
15173214
20.

Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population.

Wang J, Zhao Y, Jiang J, Gajalakshmi V, Kuriki K, Nakamura S, Akasaka S, Ishikawa H, Suzuki S, Nagaya T, Tokudome S.

J Cancer Res Clin Oncol. 2010 Oct;136(10):1517-25. doi: 10.1007/s00432-010-0809-8.

PMID:
20229274
Items per page

Supplemental Content

Support Center